RNAi technologies markets and companies

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Sunzen Biotech Bhd

Sunzen Biotech Bhd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • July 2014
  • 54 pages

A textual analysis of the financial results for Sunzen Biotech Bhd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biological Therapy | Countries: Japan

Tissue Therapies Ltd

Tissue Therapies Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • July 2014
  • 54 pages

A textual analysis of the financial results for Tissue Therapies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biological Therapy

Zhongyuan Union Stem Cell Bio-Engineering Corp

Zhongyuan Union Stem Cell Bio-Engineering Corp

  • $ 55
  • Company report
  • by Wright Investors' Service
  • July 2014
  • 56 pages

A textual analysis of the financial results for Zhongyuan Union Stem Cell Bio-Engineering Corp compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security ...

Industries: Biological Therapy

Chiome Bioscience Inc

Chiome Bioscience Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • July 2014
  • 54 pages

A textual analysis of the financial results for Chiome Bioscience Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biological Therapy | Countries: Japan

Carna Biosciences Inc

Carna Biosciences Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • July 2014
  • 56 pages

A textual analysis of the financial results for Carna Biosciences Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Biological Therapy | Countries: Japan

Shanghai Jiaoda Onlly Co., Ltd.

Shanghai Jiaoda Onlly Co., Ltd.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • July 2014
  • 56 pages

A textual analysis of the financial results for Shanghai Jiaoda Onlly Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biological Therapy

Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • by Bioseeker
  • July 2014

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies, vaccines, and immunostimulators in oncology drug development into one source. ...

Industries: Biological Therapy

Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • July 2014

There are today 120 companies plus partners developing 107 gene therapy drugs in 276 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 97 drugs. Gene Therapy In Oncology Drug Pipeline Update lists ...

Industries: Biological Therapy

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • July 2014

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 332 companies plus partners developing 441 Androgen Receptor drugs in 1457 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years ...

Industries: Biological Therapy

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • by Bioseeker
  • July 2014

Activation of the B cell receptor involves phosphorylation of the cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs) present in Ig alpha and beta. This leads to activation of several non-receptor tyrosine kinases including those of the Src, Tec and Syk family of kinases. Downstream messengers ...

Industries: Biological Therapy

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.